tiprankstipranks
Trending News
More News >
Curative Biotechnology Inc (CUBT)
:CUBT
US Market
Advertisement

Curative Biotechnology (CUBT) Income Statement

Compare
19 Followers

Curative Biotechnology Income Statement

Last quarter (Q1 2025), Curative Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Curative Biotechnology's net income was $-482.00K. See Curative Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -92.21K$ -97.52K$ -7.96K$ -6.74K$ -5.30K
Operating Expenses
$ 2.35M$ 1.83M$ 4.44M$ 5.00M$ 4.60M
Depreciation and Amortization
$ 92.21K$ 97.52K$ 99.80K$ 6.74K$ 5.30K
EBITDA
$ -2.35M$ -2.50M$ -4.36M$ -5.16M$ -4.60M
Operating Income
$ -2.44M$ -1.93M$ -4.47M$ -5.01M$ -4.64M
Other Income/Expenses
$ -1.12M$ -2.02M$ -913.57K$ -326.00K$ -34.52K
Pretax Income
$ -3.56M$ -3.96M$ -5.38M$ -5.34M$ -4.67M
Net Income
$ -3.56M$ -3.96M$ -5.38M$ -5.34M$ -4.67M
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ -0.01$ -0.04$ -0.01
Diluted EPS
$ 0.00$ -0.01$ -0.01$ -0.04$ -1.37
Weighted Average Shares Outstanding
907.91M 662.16M 562.80M 500.98M 327.85M
Weighted Average Shares Outstanding (Diluted)
907.91M 662.16M 572.01M 322.80M 3.40M
Currency in USD

Curative Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis